ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2012

Abstract Number: 2492

Protective and Pathogenic Effects of the IL-23 Family of Cytokines in Spondyloarthropathy in SKG Mice

Helen Benham1, Linda Rehaume1, Merja Ruutu1, Jared Velasco1, Kristine Kikly2, Geoffrey Strutton3, Michael McGuckin4 and Ranjeny Thomas1, 1Diamantina Institute, Diamantina Institute University of Queensland, Brisbane, Australia, 2Biotechnology Discovery Research, Eli Lilly and Co., Indianapolis, 3Dept of Pathology, Department of Pathology, Princess Alexandra Hospital, Brisbane, Australia, 4Mater Medical Research Institute, Brisbane, Australia

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Spondylarthropathy

Session Information

Title: Spondyloarthritis and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: , IL-23 is required for the expansion and maintenance of T cells and innate cells secreting IL-17 and IL-22. These cytokines are important for control of fungal infections. Genetic studies implicate IL-23 receptor signalling in the pathogenesis of spondyloarthropathies. Spondyloarthritis and Crohn’s-like ileitis develop in an IL-23-dependent fashion in ZAP70-mutant SKG mice, which have deficient T cell receptor signalling. Our aim was to determine the role of IL-23, IL-17 and IL-22 in pathogenesis of spondyloarthritis and ileitis in this model.

Methods: , SKG mice or IL-17A deficient SKG mice were injected intraperitoneally with curdlan (1,3-D β-glucan) to induce disease. Anti-mouse IL-22, anti-IL-23 or isotype control antibodies were given i.p one day before curdlan, and weekly until sacrifice and anti-mouse IL-23 and IL-17A or isotype control antibodies were given in weekly doses commencing three weeks after i.p curdlan in a treatment regime. Outcomes were measured by clinical and histological scoring. Cytokines were measured by quantitative RT-PCR and in supernatants of cultured tissue explants.

Results: Curdlan induced spondyloarthritis in 100% and ileitis in 60% of SKG mice. Weekly anti-IL-23 treatment of SKG mice from induction suppressed development of spondyloarthritis and decreased the severity of ileitis. In curdlan-treated IL-17A deficient SKG mice, or SKG mice treated with anti-IL-17 from induction, spondyloarthritis and ileitis were less severe than control treated mice. In absence of IL-17A, peripheral enthesitis was particularly spared. Treatment with anti-IL-23 or anti-IL-17 three weeks after induction improved spondyloarthritis and ileitis, and anti-IL-23 was significantly more beneficial than anti-IL17. In contrast, anti-IL-22 modestly suppressed arthritis, increased anti-proteoglycan auto antibodies, and exacerbated ileitis. IL-23 mRNA and protein were expressed within days of induction, and increased over time in the ileum, but not in serum, lymph nodes or joint.

Conclusion: In curdlan-treated SKG mice, initiation and perpetuation of spondyloarthritis is dependent on IL-23, likely derived from the gut. IL-17A is particularly associated with enthesitis. Ileal inflammation is dependent on IL-23 and IL-17A and protected by IL-22. The data suggest that beta-glucan promotes IL-23 secretion, with protective and pathogenic consequences in different tissues through T cell cytokines downstream.  Defective T cell signalling in SKG mice not only hinders negative selection of self-reactive T cells but also microbial defence, potentially enhancing the requirement for innate immune mechanisms, including IL-23,  IL-17 and IL-22 for host protection.

 


Disclosure:

H. Benham,
None;

L. Rehaume,
None;

M. Ruutu,
None;

J. Velasco,
None;

K. Kikly,
None;

G. Strutton,
None;

M. McGuckin,
None;

R. Thomas,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/protective-and-pathogenic-effects-of-the-il-23-family-of-cytokines-in-spondyloarthropathy-in-skg-mice/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology